Global Cardiac Biomarkers Market Report 2024

Cardiac Biomarkers Global Market Report 2024 – By Biomarkers Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types), By Location Of Testing (Point Of Care Testing, Laboratory Testing), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications), By End User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cardiac Biomarkers Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cardiac Biomarkers Market Definition And Segments

Cardiac biomarkers are chemicals released by heart into the blood when it is injured or under stress. It used for the detection and measurement of various cardiac vascular diseases.

The main types of cardiac biomarkers are creatine kinase (CK-MB), trophonins, myoglobin, natriuretic peptides (BNP and NT-proBNP), ischemia-modified albumin (IMA), and others. Creatine kinase (CK) is an enzyme found in various tissues in the body, including muscle and brain tissue, used in the diagnosis of myocardial infarction (MI), commonly known as a heart attack. They are used at locations such as point-of-care testing and laboratory testing in a variety of applications, including testing for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), atherosclerosis, and others. These are used by hospitals and specialty clinics.

The cardiac biomarkers market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications

4) By End User: Hospitals, Specialty Clinics

The cardiac biomarkers market size has grown rapidly in recent years. It will grow from $17.22 billion in 2023 to $19.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increased healthcare expenditure, FDA approvals and regulatory support, aging population, awareness programs, high sensitivity troponin tests, increasing cardiovascular diseases.

The cardiac biomarkers market size is expected to see rapid growth in the next few years. It will grow to $31.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to rising burden of chronic diseases, growing emphasis on early disease detection, expansion of geriatric population, emerging markets development, focus on biomarker panels. Major trends in the forecast period include patient-centric healthcare models, ai and machine learning applications, digital health integration, technological innovations in biomarker discovery, multi-marker panels, liquid biopsy in cardiovascular medicine.

Rising Prevalence Of Cardiovascular Disorders Drives Expansion Of Cardiac Biomarker Market

The rising prevalence of cardiovascular disorders is expected to propel the growth of the cardiac biomarker market going forward. Cardiovascular disorders are diseases that affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. Cardiac biomarkers are released into the bloodstream in response to certain cardiovascular disorders, such as myocardial infarction (heart attack), heart failure, and arrhythmias, which can be measured using laboratory tests, and their levels can provide important diagnostic and prognostic information. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based public agency, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021, and about 1 in 20 adults aged 20 and older had CAD. In addition, about 2 in 10 deaths from CAD happen to adults less than 65 years old. Therefore, the rising prevalence of cardiovascular disorders is driving the growth of the cardiac biomarker market.

Healthcare Expenditure Surge Fuels Expansion Of The Cardiac Biomarker Market

The rise in healthcare expenditures is expected to propel the growth of the cardiac biomarker market going forward. Health expenditures refer to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help with a focus on health. Healthcare expenditure on cardiac biomarkers aims to improve early detection, personalized treatment, and efficient resource allocation, potentially reducing overall costs associated with cardiovascular diseases. For instance, in December 2022, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, spending on health care in the United States increased 2.7% to $12,914 per person in 2021, or $4.3 trillion. Furthermore, spending on healthcare accounted for 18.3% of the country's GDP. Therefore, the rise in healthcare expenditures is driving the growth of the cardiac biomarker market.

Major companies operating in the cardiac biomarkers market report are bioMerieux Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific Inc., Creative Diagnostics, Randox Laboratories Ltd., Becton Dickinson and Company, Tosoh Corporation, Life Diagnostics, PerkinElmer Inc., Quidel Corporation, ACS Biomarker BV, LSI Medience Corp., BioDot, Alere Inc., Biosensors International Group, Biosynex SA, CardioGenics Holdings Inc., Danaher Corporation, Cortez Diagnostics Inc., DIALAB GmbH, Eurolyser Diagnostica GmbH, Grifols SA, Hologic Inc., InfraRedx Inc., Labcorp Corp., Lepu Medical Technology, Myriad Genetics, Nanosphere Inc., Biora Therapeutics Inc., Quest Diagnostics

Key Players Introduce Advanced Solutions In Cardiac Biomarker Market

Technological advancements are a key trend gaining popularity in the cardiac biomarker market. Companies operating in the cardiac biomarker market are adopting new technologies to sustain their position in the market. For instance, in April 2021, Roche Diagnostics, a Switzerland-based healthcare company, introduced five new solutions for two significant cardiac biomarkers, highly sensitive cardiac troponin T (cTnT-hs) and the N-terminal pro-brain natriuretic peptide test (NT-proBNP), using Elecsys technology. These solutions support cardiac risk identification and improve diagnosis and help identify cardiovascular risk, better diagnose patients and support early treatment.

Companies Expands Cardiac Biomarker Portfolio With Innovative Assays For Improved Cardiovascular Disease Management

Major companies operating in the cardiac biomarker markets are focused on developing innovative assays to expand their product portfolios to improve patient outcomes and address unmet medical needs. Innovative biomarker assays drive advancements in cardiac diagnostics, enhancing accuracy and expanding diagnostic capabilities. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based medical devices and solutions provider company, launched two new high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions enhance Mindray's diverse portfolio of cardiac biomarkers for diagnosing and managing cardiovascular diseases (CVDs).

Mindray's Strategic Acquisition Of HyTest Expands Global Presence In Cardiac Biomarker Domain

In September 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based medical devices, and solutions provider, acquired HyTest Ltd. for an undisclosed amount. With this acquisition, Mindray aims to strengthen its position in the global IVD market and expand its presence in Europe and other international markets. Also, Mindray aims to further advance its research and development efforts and encourage the exploration of new technologies and academic collaborations. HyTest Ltd. is a Finland-based provider of in-vitro diagnostic (IVD) reagents with expertise in cardiac biomarkers.

North America was the largest region in the cardiac biomarkers market in 2023. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac biomarkers market consists of sales of assays and reagents, point-of-care testing (POCT) devices, instruments, and software solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cardiac biomarkers market research report is one of a series of new reports from The Business Research Company that provides cardiac biomarkers market statistics, including cardiac biomarkers industry global market size, regional shares, competitors with a cardiac biomarkers market share, detailed cardiac biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac biomarkers industry. This cardiac biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiac Biomarkers Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $19.48 billion
Revenue Forecast In 2033 $31.88 billion
Growth Rate CAGR of 13.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications
4) By End User: Hospitals, Specialty Clinics
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled bioMerieux Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche AG; Siemens AG; Thermo Fisher Scientific Inc.; Creative Diagnostics; Randox Laboratories Ltd.; Becton Dickinson and Company; Tosoh Corporation; Life Diagnostics; PerkinElmer Inc.; Quidel Corporation; ACS Biomarker BV; LSI Medience Corp.; BioDot; Alere Inc.; Biosensors International Group; Biosynex SA; CardioGenics Holdings Inc.; Danaher Corporation; Cortez Diagnostics Inc.; DIALAB GmbH; Eurolyser Diagnostica GmbH; Grifols SA; Hologic Inc.; InfraRedx Inc.; Labcorp Corp.; Lepu Medical Technology; Myriad Genetics; Nanosphere Inc.; Biora Therapeutics Inc.; Quest Diagnostics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cardiac Biomarkers Market Characteristics

    3. Cardiac Biomarkers Market Trends And Strategies

    4. Cardiac Biomarkers Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cardiac Biomarkers Market Size and Growth

    5.1. Global Cardiac Biomarkers Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cardiac Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cardiac Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cardiac Biomarkers Market Segmentation

    6.1. Global Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Creatine Kinase (CK-Mb)

    Troponins

    Myoglobin

    Natriuretic Peptides (BNP And NT-proBNP)

    Ischemia Modified Albumin (IMA)

    Other Biomarker Types

    6.2. Global Cardiac Biomarkers Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Point Of Care Testing

    Laboratory Testing

    6.3. Global Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Myocardial Infarction

    Congestive Heart Failure

    Acute Coronary Syndrome (ACS)

    Atherosclerosis

    Other Applications

    6.4. Global Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    7. Cardiac Biomarkers Market Regional And Country Analysis

    7.1. Global Cardiac Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cardiac Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cardiac Biomarkers Market

    8.1. Asia-Pacific Cardiac Biomarkers Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cardiac Biomarkers Market

    9.1. China Cardiac Biomarkers Market Overview

    9.2. China Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cardiac Biomarkers Market

    10.1. India Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cardiac Biomarkers Market

    11.1. Japan Cardiac Biomarkers Market Overview

    11.2. Japan Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cardiac Biomarkers Market

    12.1. Australia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cardiac Biomarkers Market

    13.1. Indonesia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cardiac Biomarkers Market

    14.1. South Korea Cardiac Biomarkers Market Overview

    14.2. South Korea Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cardiac Biomarkers Market

    15.1. Western Europe Cardiac Biomarkers Market Overview

    15.2. Western Europe Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cardiac Biomarkers Market

    16.1. UK Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cardiac Biomarkers Market

    17.1. Germany Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cardiac Biomarkers Market

    18.5. France Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cardiac Biomarkers Market

    19.9. Italy Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cardiac Biomarkers Market

    20.13. Spain Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cardiac Biomarkers Market

    21.1. Eastern Europe Cardiac Biomarkers Market Overview

    21.2. Eastern Europe Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cardiac Biomarkers Market

    22.1. Russia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cardiac Biomarkers Market

    23.1. North America Cardiac Biomarkers Market Overview

    23.2. North America Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cardiac Biomarkers Market

    24.1. USA Cardiac Biomarkers Market Overview

    24.2. USA Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cardiac Biomarkers Market

    25.1. Canada Cardiac Biomarkers Market Overview

    25.2. Canada Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cardiac Biomarkers Market

    26.1. South America Cardiac Biomarkers Market Overview

    26.2. South America Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cardiac Biomarkers Market

    27.1. Brazil Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cardiac Biomarkers Market

    28.1. Middle East Cardiac Biomarkers Market Overview

    28.2. Middle East Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cardiac Biomarkers Market

    29.1. Africa Cardiac Biomarkers Market Overview

    29.2. Africa Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cardiac Biomarkers Market Competitive Landscape And Company Profiles

    30.1. Cardiac Biomarkers Market Competitive Landscape

    30.2. Cardiac Biomarkers Market Company Profiles

    30.2.1. BioMerieux Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bio-Rad Laboratories

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Siemens AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Thermo Fisher Scientific Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cardiac Biomarkers Market Competitive Benchmarking

    32. Global Cardiac Biomarkers Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cardiac Biomarkers Market

    34. Cardiac Biomarkers Market Future Outlook and Potential Analysis

    34.1 Cardiac Biomarkers Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cardiac Biomarkers Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cardiac Biomarkers Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cardiac Biomarkers Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cardiac Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Cardiac Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: BioMerieux Inc. Financial Performance
  • Table 76: Bio-Rad Laboratories Financial Performance
  • Table 77: F. Hoffmann-La Roche AG Financial Performance
  • Table 78: Siemens AG Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cardiac Biomarkers Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cardiac Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Cardiac Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: BioMerieux Inc. Financial Performance
  • Figure 76: Bio-Rad Laboratories Financial Performance
  • Figure 77: F. Hoffmann-La Roche AG Financial Performance
  • Figure 78: Siemens AG Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Pacemakers Global Market Report 2024 – By Type (MRI Compatible Pacemaker, Conventional Pacemaker ), By Technology (Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular or CRT Pacemaker), By Implantability (Implantable Pacemaker, External Pacemaker), By Application (Congestive Heart Failure, Arrhythmias, Bradycardia, Tachycardia), By End-User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Assist Devices And Equipment Global Market Report 2024 – By Type (Ventricular Assist Devices (LVAD), Intra-Aortic Balloon Pumps, Total Artificial Heart), By Modality (Transcutaneous, Implantable), By Application (Hospital Pharmacies, Ambulatory Surgical Centres, Emergency Services ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024 – By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), By Application (Bradycardia, Tachycardia, Heart Failure, Other Applications), By End User (Hospitals, Ambulatory surgical centers, Physicians Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Valve Global Market Report 2024 – By Type (Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types), By Position (Aortic Valve, Mitral Valve, Other Positions), By Treatment (Cardiac Valve Repair, Cardiac Valve Replacement), By End-Users (Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Devices Global Market Report 2024 – By Type (Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024 – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems), By Type (Heart Disease, Coronary Heart Disease), By End-Use (Hospitals/Physician Clinic (Continuous Glucose Monitors), Home/Emergency, Research and Development (Clinical Trials, Universities, CRO)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Surgery Devices And Equipment Global Market Report 2024 – By Product Type (Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications), By End User (Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Frequently Asked Questions

What is the definition of the cardiac biomarkers market?

Cardiac biomarkers are chemicals released by heart into the blood when it is injured or under stress. It used for the detection and measurement of various cardiac vascular diseases. For further insights on the cardiac biomarkers market, request a sample here

How will the cardiac biomarkers market drivers and restraints affect the cardiac biomarkers market dynamics? What forces will shape the cardiac biomarkers industry going forward?

The cardiac biomarkers market major growth driver - rising prevalence of cardiovascular disorders drives expansion of cardiac biomarker market. For further insights on the cardiac biomarkers market, request a sample here

What is the forecast market size or the forecast market value of the cardiac biomarkers market ?

The cardiac biomarkers market size has grown rapidly in recent years. It will grow from $17.22 billion in 2023 to $19.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increased healthcare expenditure, fda approvals and regulatory support, aging population, awareness programs, high sensitivity troponin tests, increasing cardiovascular diseases. The cardiac biomarkers market size is expected to see rapid growth in the next few years. It will grow to $31.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to rising burden of chronic diseases, growing emphasis on early disease detection, expansion of geriatric population, emerging markets development, focus on biomarker panels. Major trends in the forecast period include patient-centric healthcare models, ai and machine learning applications, digital health integration, technological innovations in biomarker discovery, multi-marker panels, liquid biopsy in cardiovascular medicine. For further insights on the cardiac biomarkers market, request a sample here

How is the cardiac biomarkers market segmented?

The cardiac biomarkers market is segmented
1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications
4) By End User: Hospitals, Specialty ClinicsFor further insights on the cardiac biomarkers market, request a sample here

Which region has the largest share of the cardiac biomarkers market? What are the other regions covered in the report?

North America was the largest region in the cardiac biomarkers market in 2023. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the cardiac biomarkers market, request a sample here.

Who are the major players in the cardiac biomarkers market?

Major companies operating in the cardiac biomarkers market report are bioMerieux Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific Inc., Creative Diagnostics, Randox Laboratories Ltd., Becton Dickinson and Company, Tosoh Corporation, Life Diagnostics, PerkinElmer Inc., Quidel Corporation, ACS Biomarker BV, LSI Medience Corp., BioDot, Alere Inc., Biosensors International Group, Biosynex SA, CardioGenics Holdings Inc., Danaher Corporation, Cortez Diagnostics Inc., DIALAB GmbH, Eurolyser Diagnostica GmbH, Grifols SA, Hologic Inc., InfraRedx Inc., Labcorp Corp., Lepu Medical Technology, Myriad Genetics, Nanosphere Inc., Biora Therapeutics Inc., Quest Diagnostics For further insights on the cardiac biomarkers market, request a sample here.

What are the key trends in the cardiac biomarkers market?

Major trend in the cardiac biomarkers market - key players introduce advanced solutions in cardiac biomarker market. For further insights on the cardiac biomarkers market, request a sample here.

What are the major opportunities in the cardiac biomarkers market? What are the strategies for the cardiac biomarkers market?

For detailed insights on the major opportunities and strategies in the cardiac biomarkers market, request a sample here.

How does the cardiac biomarkers market relate to the overall economy and other similar markets?

For detailed insights on cardiac biomarkers market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cardiac biomarkers industry?

For detailed insights on the mergers and acquisitions in the cardiac biomarkers industry, request a sample here.

What are the key dynamics influencing the cardiac biomarkers market growth? SWOT analysis of the cardiac biomarkers market.

For detailed insights on the key dynamics influencing the cardiac biomarkers market growth and SWOT analysis of the cardiac biomarkers industry, request a sample here.